Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients

Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients

Valganciclovir (VGC) is administered as prophylaxis to kidney transplant recipients (KTR) CMV donor (D)+/recipient (R)− and CMV R+ after thymoglobulin-induction (R+/TG). Although VGC dose adjustments based on renal function are recommended, there is paucity of real-life data on VGC dosing and associ...

Full description

Bibliographic Details
Main Authors: Nathalie Hammer, Linard Hoessly, Fadi Haidar, Cédric Hirzel, Sophie de Seigneux, Christian van Delden, Bruno Vogt, Daniel Sidler, Dionysios Neofytos
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-05-01
Series:Transplant International
Subjects:
cytomegalovirus
valganciclovir
renal function
kidney transplantation
dosing
Online Access:https://www.frontierspartnerships.org/articles/10.3389/ti.2024.12712/full

Internet

https://www.frontierspartnerships.org/articles/10.3389/ti.2024.12712/full

Similar Items